HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Baldwin, D. Search for Related Content PubMed Articles by Baldwin, D.

Psychotropic Drug Directory 2003/04. The Professionals' Pocket Handbook & Aide Memoire

Stephen Bazire

Clinical Neuroscience Division, Faculty of Medicine, Health and Life Sciences, University of Southampton

Salisbury: Fivepin Publishing, 2003, £24.99 pb, 416 pp, ISBN: 0 95 448839 01

Rock bands fear releasing ‘the difficult third album’. Marriages are unsettled by the seven-year ‘itch’. Over repeated editions, initially successful and much-respected books become jaded and unnecessary. This familiar handbook, often made available to prescribing doctors by pharmaceutical company representatives, has entered its second decade. Has it survived the journey intact?

In the foreword, Stephen Bazire states this directory contains over 1000 new references, with major changes throughout the text. He has adopted a new approach to the chapter devoted to selecting drugs, doses and preparations; to the description of sexual side-effects; and in the account of drug-drug interactions. He has included material relating to drugs recently available for clinical use (memantine and aripiprazole). As in previous editions, sections are arranged in a problem-orientated manner, supported by extensive references, with emphasis on recent review articles and original research papers.

Reading the book from cover to cover would occupy a few days, but is probably not the best approach to assessing its value in supporting practice. Instead I took it to out-patient clinics for a few weeks, to see whether it resolved clinical queries and conundrums. A second challenge was to see how it addressed some admittedly rather idiosyncratic current research interests, i.e. the treatment of anxiety disorders and bipolar depression, and sexual dysfunction with antidepressants.

It seems pretty robust: in just one clinic, it helped resolve queries regarding co-administration of lamotrigine and sodium valproate; the possible combination of bupropion with a selective serotonin reuptake inhibitor; and weight gain with paroxetine. Some of these matters were not resolved by prior consultation of the British National Formulary. As implied in the foreword, it proved less consistently valuable in providing data for developing research questions, largely due to the delay between manuscript submission and book publication.

Unnecessary and jaded? No; still needed, and surprisingly chirpy.

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Baldwin, D. Search for Related Content PubMed Articles by Baldwin, D.